| pubmed-article:17220912 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17220912 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:17220912 | lifeskim:mentions | umls-concept:C0006104 | lld:lifeskim |
| pubmed-article:17220912 | lifeskim:mentions | umls-concept:C0023693 | lld:lifeskim |
| pubmed-article:17220912 | lifeskim:mentions | umls-concept:C0336791 | lld:lifeskim |
| pubmed-article:17220912 | lifeskim:mentions | umls-concept:C1872922 | lld:lifeskim |
| pubmed-article:17220912 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:17220912 | pubmed:dateCreated | 2007-2-20 | lld:pubmed |
| pubmed-article:17220912 | pubmed:abstractText | The discovery of JP-1302 as a selective, high affinity antagonist at the alpha2C-adrenoceptor will enable researchers to probe the functional role and address the therapeutic utility of this potentially highly important adrenoceptor subtype. | lld:pubmed |
| pubmed-article:17220912 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17220912 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17220912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17220912 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17220912 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:17220912 | pubmed:issn | 0007-1188 | lld:pubmed |
| pubmed-article:17220912 | pubmed:author | pubmed-author:TricklebankM... | lld:pubmed |
| pubmed-article:17220912 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17220912 | pubmed:volume | 150 | lld:pubmed |
| pubmed-article:17220912 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17220912 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17220912 | pubmed:pagination | 381-2 | lld:pubmed |
| pubmed-article:17220912 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:17220912 | pubmed:meshHeading | pubmed-meshheading:17220912... | lld:pubmed |
| pubmed-article:17220912 | pubmed:meshHeading | pubmed-meshheading:17220912... | lld:pubmed |
| pubmed-article:17220912 | pubmed:meshHeading | pubmed-meshheading:17220912... | lld:pubmed |
| pubmed-article:17220912 | pubmed:meshHeading | pubmed-meshheading:17220912... | lld:pubmed |
| pubmed-article:17220912 | pubmed:meshHeading | pubmed-meshheading:17220912... | lld:pubmed |
| pubmed-article:17220912 | pubmed:meshHeading | pubmed-meshheading:17220912... | lld:pubmed |
| pubmed-article:17220912 | pubmed:meshHeading | pubmed-meshheading:17220912... | lld:pubmed |
| pubmed-article:17220912 | pubmed:meshHeading | pubmed-meshheading:17220912... | lld:pubmed |
| pubmed-article:17220912 | pubmed:meshHeading | pubmed-meshheading:17220912... | lld:pubmed |
| pubmed-article:17220912 | pubmed:meshHeading | pubmed-meshheading:17220912... | lld:pubmed |
| pubmed-article:17220912 | pubmed:meshHeading | pubmed-meshheading:17220912... | lld:pubmed |
| pubmed-article:17220912 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17220912 | pubmed:articleTitle | JP-1302: a new tool to shed light on the roles of alpha2C-adrenoceptors in brain. | lld:pubmed |
| pubmed-article:17220912 | pubmed:affiliation | Discovery Biology, Eli Lilly and Co. Ltd, Erl Wood Manor, Windlesham, Surrey, UK. TRICKLEBANK_MARK@Lilly.com | lld:pubmed |
| pubmed-article:17220912 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17220912 | pubmed:publicationType | Comment | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17220912 | lld:pubmed |
